semaglutide afib GLP-1 drugs outperform SGLT-2 drugs for patients with and type 2 diabetes Semaglutide: more than weight loss?
Description
Diarrhoea or constipation may develop or worsen
British Journal of Pharmacology, 179 (4), 727742
The recent FDA approval of the oral Wegovy pill provides an alternative for those who prefer non-injectable options
These effects were often more noticeable when doses were increased
